- API
 - Ivabradine hydrochlorid
 - Rivaroxaban
 - Apixaban
 - Dabigatran etexilate
 - Safinamide
 - Ticlopidine hydrochloride
 - Mirtazapine
 - Clopidogrel bisulfate
 - Duloxetine hydrochloride
 - Rebamipide
 - Intermediates
 - Duloxetine intermediate
 - Clopidogrel intermediate
 - Mirtazapine intermediates
 - Dabigatran etexilate intermediates
 - Lurasidone intermediates
 - Bepotastine intermediates
 - Asenapine Intermediates
 - Drotaverine intermediates
 - Prasugrel Intermediates
 - Ivabradine、Verapamil, Denopamine intermediates
 - Moxifloxacin intermediate
 - Ticagrelor intermediate <Under Development>
 - Canagliflozin intermediate
 - Ivabradine intermediate
 
Address:  Zhejiang Provincial Chemical and Medical Raw Material Base Linhai Zone, Duqiao Town, Linhai City, Zhejiang Province, 317016, China
Tel / Fax: 0576-85588211
Tel / Fax: 0576-85588211
| Product Name | Structure | CAS No. | Specification | Use | Classification | 
| (+)Clopidogrel(-)camphorsulphonic acid | ![]()  | 
        120202-68-8 | Assay:≥98.0-102.0% Optical Purity:≥99% | Commerical | Clopidogrel intermediate | 
| 1-(3-Hydroxymethylpyridin-2-yl)-4-methyl-2-phenylpiperazine | ![]()  | 
        61337-89-1 | Assay:≥99% Water:≤0.5% | Commerical | Mirtazapine intermediates | 
| 1-(3-Carboxy-2-pyridyl)-4-methyl-2-phenylpiperazine | ![]()  | 
        61338-13-4 | Assay:≥99% Water:≤0.5% | Commerical | Mirtazapine intermediates | 
| 3-[(3-Amino-4-methylaminobenzoyl)pyridin-2-ylamino]propionic acid ethyl ester | ![]()  | 
        212322-56-0 | Assay:≥95% Impurity:≤5.0% | Commerical | Dabigatran etexilate intermediates | 
| 2-(4-Cyanophenylamino)acetic acid | ![]()  | 
        42288-26-6 | Assay:≥99% Impurity:≤1.0% | Commerical | Dabigatran etexilate intermediates | 
| Ethyl 3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino] propionate | ![]()  | 
        211915-84-3 | Assay:≥95% Impurity:≤5.0% | Commerical | Dabigatran etexilate intermediates | 
| N-[[2-[[[4-(aminomethyl)amino]methl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride | ![]()  | 
        211914-50-0 | In-house | Commerical | Dabigatran etexilate intermediates | 
| (1R,2R)-1,2-Cyclohexanedimethanol | ![]()  | 
        65376-05-8 | Assay:≥99% Impurity:≤1.0% | Commerical | Lurasidone intermediates | 
| (3aR,4S,7R,7aS)4,7-Methano-1H-isoindole-1,3(2H)-dione | ![]()  | 
        14805-29-9 | Assay:≥99% Impurity:≤1.0% | Commerical | Lurasidone intermediates | 
| 2-[(S)-4-Chlorophenyl)(4-piperidinyloxy)methyl]pyridine | ![]()  | 
        210095-58-2 | Assay:≥95% Water:≤0.5% | Commerical | Bepotastine intermediates | 

  
  










